Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway

Cardiovascular Research

Volumn 93, Issue 1, 2012, Pages 69-78

  Cui, Xiao Bing ^a,b   Wang, Cheng ^a,b   Li, Li ^a,b   Fan, Dong ^a,b   Zhou, Yun ^a,b   Wu, Dan ^a,b   Cui, Qing Hua ^a   Fu, Feng Ying ^a,b   Wu, Li Ling ^a,b,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Adiponectin receptor; Cardiomyocyte; FoxO1; Insulin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOSOL; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; HEART MUSCLE CELL; HYPERINSULINEMIA; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; INSULIN; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; MYOCYTES, CARDIAC; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84555186814     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr273     Document Type: Article

References (37)

1. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935. (Pubitemid 32472900)
2. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-89. (Pubitemid 36091630)
3. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277: 25863-25866. (Pubitemid 34967064)
4. Liao Y, Takashima S, Maeda N, Ouchi N, Komamura K, Shimomura I et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc Res 2005;67:705-713. (Pubitemid 41033366)
5. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946. (Pubitemid 32756432)
6. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR et al. Adiponectinmediated modulation of hypertrophic signals in the heart. Nat Med 2004;10: 1384-1389. (Pubitemid 40022722)
7. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med 2005;11:1096-1103. (Pubitemid 41486832)
8. Shibata R, Sato K, Kumada M, Izumiya Y, Sonoda M, Kihara S et al. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. Cardiovasc Res 2007;74:471-479. (Pubitemid 46693703)
9. Kersten S, Desvergne B, WahliW. Roles of PPARs in health and disease. Nature 2000; 405:421-424. (Pubitemid 30367411)
10. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-1295. (Pubitemid 35373562)
11. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423: 762-769. (Pubitemid 36735700)
12. Civitarese AE, Jenkinson CP, Richardson D, Bajaj M, Cusi K, Kashyap S et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes. Diabetologia 2004; 47:816-820. (Pubitemid 38756993)
13. Saito Y, Fujioka D, Kawabata K, Kobayashi T, Yano T, Nakamura T et al. Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake. Am J Physiol Heart Circ Physiol 2007;293:H3490-H3497. (Pubitemid 350230892)
14. Bluher M, Bullen JW Jr, Lee JH, Kralisch S, Fasshauer M, Kloting N et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab 2006;91:2310-2316. (Pubitemid 43855022)
15. Barnea M, Shamay A, Stark AH, Madar Z. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 2006;14: 2145-2153. (Pubitemid 46121969)
16. Guo Z, Zheng C, Qin Z, Wei P. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats. J Pharm Pharmacol 2010;63: 87-94.
17. Guo Z, Xia Z, Yuen VG, McNeill JH. Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats. Metabolism 2007;56:1363-1371. (Pubitemid 47404598)
18. Yu W, Chen C, Fu Y, Wang X, Wang W. Insulin signaling: a possible pathogenesis of cardiac hypertrophy. Cardiovasc Ther 2010;28:101-105.
19. Wang C, Li L, Zhang ZG, Fan D, Zhu Y, Wu LL. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy. J Cell Physiol 2010;222:149-155.
20. Zhao Y, Liu J, Li L, Liu L, Wu L. Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul Pept 2005;128: 43-50. (Pubitemid 40255533)
21. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000;103:843-852.
22. Fang X, Palanivel R, Zhou X, Liu Y, Xu A, Wang Y et al. Hyperglycemia-and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J Mol Endocrinol 2005;35:465-476. (Pubitemid 43025572)
23. Bertrand L, Horman S, Beauloye C, Vanoverschelde JL. Insulin signalling in the heart. Cardiovasc Res 2008;79:238-248. (Pubitemid 351951609)
24. McKinnon CM, Ravier MA, Rutter GA. FoxO1 is required for the regulation of preproglucagon gene expression by insulin in pancreatic alphaTC1-9 cells. J Biol Chem 2006;281:39358-39369. (Pubitemid 46041895)
25. Inukai K, Nakashima Y, Watanabe M, Takata N, Sawa T, Kurihara S et al. Regulation of adiponectin receptor gene expression in diabetic mice. Am J Physiol Endocrinol Metab 2005;288:E876-E882. (Pubitemid 40547880)
26. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004;279:30817-30822. (Pubitemid 38938015)
27. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M et al. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett 2004; 558:27-32. (Pubitemid 38167405)
28. Juan CC, Shen YW, Chien Y, Lin YJ, Chang SF, Ho LT. Insulin infusion induces endothelin-1-dependent hypertension in rats. Am J Physiol Endocrinol Metab 2004; 287:E948-E954. (Pubitemid 39382932)
29. Samuelsson AM, Bollano E, Mobini R, Larsson BM, Omerovic E, Fu M et al. Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways. Am J Physiol Heart Circ Physiol 2006;291:H787-H796. (Pubitemid 44175086)
30. Murray AJ, Lygate CA, Cole MA, Carr CA, Radda GK, Neubauer S et al. Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart. Cardiovasc Res 2006;71:149-157. (Pubitemid 43849666)
31. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-1737. (Pubitemid 38489895)
32. Ma Y, Liu Y, Liu S, Qu Y, Wang R, Xia C et al. Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice. Am J Physiol Endocrinol Metab 2011;301:E447-E455.
33. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332-339. (Pubitemid 46376688)
34. Sun X, He J, Mao C, Han R, Wang Z, Liu Y et al. Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element. FEBS Lett 2008;582:3401-3407.
35. Ng Y, Ramm G, James DE. Dissecting the mechanism of insulin resistance using a novel heterodimerization strategy to activate Akt. J Biol Chem 2010;285:5232-5239.
36. Liu HY, Hong T, Wen GB, Han J, Zuo D, Liu Z et al. Increased basal level of Aktdependent insulin signaling may be responsible for the development of insulin resistance. Am J Physiol Endocrinol Metab 2009;297:E898-E906.
37. Felder TK, Hahne P, Soyal SM, Miller K, Hoffinger H, Oberkofler H et al. Hepatic adiponectin receptors (ADIPOR) 1 and 2 mRNA and their relation to insulin resistance in obese humans. Int J Obes (Lond) 2010;34:846-851.